Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma.
Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...
Shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) have been given an average rating of “Buy” by the six analysts that are currently covering the stock, MarketBeat Ratings reports.
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today and set a price target of $37.00. The company’s shares closed ...
Lucas Hunter loves to kite surf, so along with his sister Sophie he planned a trip to Colombia to take advantage of the “good waves” in the north of the country in late December last year.
NewAmsterdam Pharma has a fifty-two week low of $15.19 and a fifty-two week high of $27.29. NewAmsterdam Pharma ( NASDAQ:NAMS – Get Free Report ) last released its quarterly earnings data on ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand ...
Amsterdam is largely below sea level, so concerns about climate change — and local, sustainable ingredients — are ever present. The relative lack of cars makes al fresco dining in the city ...
CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann Swiss pharmaceutical giant Novartis says ...
Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...
Story Jan. 10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM ...
After hours: March 14 at 5:05:00 PM EDT Loading Chart for KRG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results